Immunodiagnostics Market By Product Type , By Technology By Application By End-user : Global Opportunity Analysis and Industry Forecast, 2024-2033

Description

The immunodiagnostics market was valued at $24.2 billion in 2023, and is projected to reach $36.4 billion by 2033, growing at a CAGR of 4.1% from 2024 to 2033.

Immunodiagnostics are tests that involve the use of antigen-antibody responses to identify, target, and eliminate pathogens or foreign substances. It serves as a powerful technique to detect a wide range of targets and thus finds its major application in the fields of infectious diseases and autoimmune disease detection, food safety, and cancer diagnostics. The most common Immunodiagnostics techniques include enzyme-linked immunosorbent assay (ELISA), radioimmunoassays, fluorescent immunoassays, and lateral flow assays.

The growth of the global immunodiagnostics market is majorly driven by alarming increase in prevalence of chronic diseases such as cancer, cardiovascular diseases, gastrointestinal disorders, and other chronic diseases due to vulnerability of geriatric population to such diseases and changes in lifestyle. Furthermore, increase in environmental pollution and rise in incidence of diseases due to high exposure to pollution have boosted the demand for immunodiagnostics. Immunodiagnostic tools play a key role in detecting environmental contaminants such as dichlorodiphenyltrichloroethane (DDT), polychlorinated biphenyls (PCB), explosives, organophosphorus pesticides, and biological warfare materials. In addition, contaminants in food such as Staphylococcal enterotoxin B as well as pesticides in fruits, vegetables, and grains can be easily detected using immunodiagnostics. However, high costs associated with immunodiagnostics and reluctance in the adoption of advanced technologies in emerging economies are expected to hamper the growth of the market. On the contrary, increase in awareness about advanced preventative health measures and technologically advancements in diagnostic kits, assays, and analyzers are expected to offer remunerative opportunities for the expansion of the global immunodiagnostics market during the forecast period.

The global immunodiagnostics market is segmented into product type, technology, application, end user, and region. Depending on product type, the market is classified into reagents, instruments, and software & services.?As per technology, it is segregated into enzyme-linked immunosorbent assay, chemiluminescence immunoassay, fluorescent immunoassay, radioimmunoassay, and others. Depending on application, it is fragmented into infectious diseases, oncology & endocrinology, bone & mineral diseases, autoimmunity disorders, cardiac biomarkers, drug monitoring, and others. By end user, it is categorized into hospitals, clinical laboratories, academic & research institutes, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of product type, the reagents segment is expected to lead the market by 2033.

As per technology, the ELISA technology segment dominated the immunodiagnostics market in 2023.

Depending on application, the infectious disease segment is likely to dominate the market during the forecast period.

By end user, the clinical laboratories segment is likely to be lucrative during the forecast period.

Region wise, North America was the major revenue generator in 2023, and is likely to dominate the market during the forecast period.

Competition Analysis

Competitive analysis and profiles of the major players in the global immunodiagnostics market include Abbott, Becton Dickinson, Agilent Technologies, Inc., Exact Sciences Corporation, Guardant Health, Illumina, Inc., Diaosorin, NeoGenomics Laboratories, F. Hoffmann-La Roche Ltd., and Thermo Fisher Scientific. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the global market.

Additional benefits you will get with this purchase are:

Quarterly Update and* (only available with a corporate license, on listed price)
5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
Free Upcoming Version on the Purchase of Five and Enterprise User License.
16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
Free data Pack on the Five and Enterprise User License. (Excel version of the report)
Free Updated report if the report is 6-12 months old or older.
24-hour priority response*
Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

Patient/epidemiology data at country, region, global level
Regulatory Guidelines
Additional company profiles with specific to client's interest
Additional country or region analysis- market size and forecast
Expanded list for Company Profiles
Historic market data
SWOT Analysis

Key Market Segments

By Product Type

Reagents
Instruments
Software and Services

By Technology

Enzyme-linked immunosorbent assay
Chemiluminescence immunoassay
Fluorescent immunoassay
Radioimmunoassay
Others

By Application

Infectious diseases
Oncology endocrinology
Bone mineral diseases
Autoimmunity disorders
Cardiac biomarkers
Drug monitoring
Others

By End-user

Hospitals
Clinical Laboratories
Academic research institutes
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- Spain
- UK
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
LAMEA
- Brazil
- South Africa
- Saudi Arabia
- Rest of LAMEA

Key Market Players:

Abbott
Becton Dickinson
Agilent Technologies, Inc.
Exact Sciences Corporation
Guardant Health
Illumina, Inc.
Diaosorin
NeoGenomics Laboratories
F. Hoffmann-La Roche Ltd.
Thermo Fisher Scientific Inc.

Product Code: A01435

CHAPTER 1: INTRODUCTION

1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

3.1. Market Definition and Scope
3.2. Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities

CHAPTER 4: IMMUNODIAGNOSTICS MARKET, BY PRODUCT TYPE

4.1. Market Overview
- 4.1.1 Market Size and Forecast, By Product Type
4.2. Reagents
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Size and Forecast, By Region
- 4.2.3. Market Share Analysis, By Country
4.3. Instruments
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Size and Forecast, By Region
- 4.3.3. Market Share Analysis, By Country
4.4. Software And Services
- 4.4.1. Key Market Trends, Growth Factors and Opportunities
- 4.4.2. Market Size and Forecast, By Region
- 4.4.3. Market Share Analysis, By Country

CHAPTER 5: IMMUNODIAGNOSTICS MARKET, BY TECHNOLOGY

5.1. Market Overview
- 5.1.1 Market Size and Forecast, By Technology
5.2. Enzyme-linked Immunosorbent Assay
- 5.2.1. Key Market Trends, Growth Factors and Opportunities
- 5.2.2. Market Size and Forecast, By Region
- 5.2.3. Market Share Analysis, By Country
5.3. Chemiluminescence Immunoassay
- 5.3.1. Key Market Trends, Growth Factors and Opportunities
- 5.3.2. Market Size and Forecast, By Region
- 5.3.3. Market Share Analysis, By Country
5.4. Fluorescent Immunoassay
- 5.4.1. Key Market Trends, Growth Factors and Opportunities
- 5.4.2. Market Size and Forecast, By Region
- 5.4.3. Market Share Analysis, By Country
5.5. Radioimmunoassay
- 5.5.1. Key Market Trends, Growth Factors and Opportunities
- 5.5.2. Market Size and Forecast, By Region
- 5.5.3. Market Share Analysis, By Country
5.6. Others
- 5.6.1. Key Market Trends, Growth Factors and Opportunities
- 5.6.2. Market Size and Forecast, By Region
- 5.6.3. Market Share Analysis, By Country

CHAPTER 6: IMMUNODIAGNOSTICS MARKET, BY APPLICATION

6.1. Market Overview
- 6.1.1 Market Size and Forecast, By Application
6.2. Infectious Diseases
- 6.2.1. Key Market Trends, Growth Factors and Opportunities
- 6.2.2. Market Size and Forecast, By Region
- 6.2.3. Market Share Analysis, By Country
6.3. Oncology Endocrinology
- 6.3.1. Key Market Trends, Growth Factors and Opportunities
- 6.3.2. Market Size and Forecast, By Region
- 6.3.3. Market Share Analysis, By Country
6.4. Bone Mineral Diseases
- 6.4.1. Key Market Trends, Growth Factors and Opportunities
- 6.4.2. Market Size and Forecast, By Region
- 6.4.3. Market Share Analysis, By Country
6.5. Autoimmunity Disorders
- 6.5.1. Key Market Trends, Growth Factors and Opportunities
- 6.5.2. Market Size and Forecast, By Region
- 6.5.3. Market Share Analysis, By Country
6.6. Cardiac Biomarkers
- 6.6.1. Key Market Trends, Growth Factors and Opportunities
- 6.6.2. Market Size and Forecast, By Region
- 6.6.3. Market Share Analysis, By Country
6.7. Drug Monitoring
- 6.7.1. Key Market Trends, Growth Factors and Opportunities
- 6.7.2. Market Size and Forecast, By Region
- 6.7.3. Market Share Analysis, By Country
6.8. Others
- 6.8.1. Key Market Trends, Growth Factors and Opportunities
- 6.8.2. Market Size and Forecast, By Region
- 6.8.3. Market Share Analysis, By Country

CHAPTER 7: IMMUNODIAGNOSTICS MARKET, BY END-USER

7.1. Market Overview
- 7.1.1 Market Size and Forecast, By End-user
7.2. Hospitals
- 7.2.1. Key Market Trends, Growth Factors and Opportunities
- 7.2.2. Market Size and Forecast, By Region
- 7.2.3. Market Share Analysis, By Country
7.3. Clinical Laboratories
- 7.3.1. Key Market Trends, Growth Factors and Opportunities
- 7.3.2. Market Size and Forecast, By Region
- 7.3.3. Market Share Analysis, By Country
7.4. Academic Research Institutes
- 7.4.1. Key Market Trends, Growth Factors and Opportunities
- 7.4.2. Market Size and Forecast, By Region
- 7.4.3. Market Share Analysis, By Country
7.5. Others
- 7.5.1. Key Market Trends, Growth Factors and Opportunities
- 7.5.2. Market Size and Forecast, By Region
- 7.5.3. Market Share Analysis, By Country

CHAPTER 8: IMMUNODIAGNOSTICS MARKET, BY REGION

8.1. Market Overview
- 8.1.1 Market Size and Forecast, By Region
8.2. North America
- 8.2.1. Key Market Trends and Opportunities
- 8.2.2. Market Size and Forecast, By Product Type
- 8.2.3. Market Size and Forecast, By Technology
- 8.2.4. Market Size and Forecast, By Application
- 8.2.5. Market Size and Forecast, By End-user
- 8.2.6. Market Size and Forecast, By Country
- 8.2.7. U.S. Immunodiagnostics Market
  - 8.2.7.1. Market Size and Forecast, By Product Type
  - 8.2.7.2. Market Size and Forecast, By Technology
  - 8.2.7.3. Market Size and Forecast, By Application
  - 8.2.7.4. Market Size and Forecast, By End-user
- 8.2.8. Canada Immunodiagnostics Market
  - 8.2.8.1. Market Size and Forecast, By Product Type
  - 8.2.8.2. Market Size and Forecast, By Technology
  - 8.2.8.3. Market Size and Forecast, By Application
  - 8.2.8.4. Market Size and Forecast, By End-user
- 8.2.9. Mexico Immunodiagnostics Market
  - 8.2.9.1. Market Size and Forecast, By Product Type
  - 8.2.9.2. Market Size and Forecast, By Technology
  - 8.2.9.3. Market Size and Forecast, By Application
  - 8.2.9.4. Market Size and Forecast, By End-user
8.3. Europe
- 8.3.1. Key Market Trends and Opportunities
- 8.3.2. Market Size and Forecast, By Product Type
- 8.3.3. Market Size and Forecast, By Technology
- 8.3.4. Market Size and Forecast, By Application
- 8.3.5. Market Size and Forecast, By End-user
- 8.3.6. Market Size and Forecast, By Country
- 8.3.7. France Immunodiagnostics Market
  - 8.3.7.1. Market Size and Forecast, By Product Type
  - 8.3.7.2. Market Size and Forecast, By Technology
  - 8.3.7.3. Market Size and Forecast, By Application
  - 8.3.7.4. Market Size and Forecast, By End-user
- 8.3.8. Germany Immunodiagnostics Market
  - 8.3.8.1. Market Size and Forecast, By Product Type
  - 8.3.8.2. Market Size and Forecast, By Technology
  - 8.3.8.3. Market Size and Forecast, By Application
  - 8.3.8.4. Market Size and Forecast, By End-user
- 8.3.9. Italy Immunodiagnostics Market
  - 8.3.9.1. Market Size and Forecast, By Product Type
  - 8.3.9.2. Market Size and Forecast, By Technology
  - 8.3.9.3. Market Size and Forecast, By Application
  - 8.3.9.4. Market Size and Forecast, By End-user
- 8.3.10. Spain Immunodiagnostics Market
  - 8.3.10.1. Market Size and Forecast, By Product Type
  - 8.3.10.2. Market Size and Forecast, By Technology
  - 8.3.10.3. Market Size and Forecast, By Application
  - 8.3.10.4. Market Size and Forecast, By End-user
- 8.3.11. UK Immunodiagnostics Market
  - 8.3.11.1. Market Size and Forecast, By Product Type
  - 8.3.11.2. Market Size and Forecast, By Technology
  - 8.3.11.3. Market Size and Forecast, By Application
  - 8.3.11.4. Market Size and Forecast, By End-user
- 8.3.12. Rest of Europe Immunodiagnostics Market
  - 8.3.12.1. Market Size and Forecast, By Product Type
  - 8.3.12.2. Market Size and Forecast, By Technology
  - 8.3.12.3. Market Size and Forecast, By Application
  - 8.3.12.4. Market Size and Forecast, By End-user
8.4. Asia-Pacific
- 8.4.1. Key Market Trends and Opportunities
- 8.4.2. Market Size and Forecast, By Product Type
- 8.4.3. Market Size and Forecast, By Technology
- 8.4.4. Market Size and Forecast, By Application
- 8.4.5. Market Size and Forecast, By End-user
- 8.4.6. Market Size and Forecast, By Country
- 8.4.7. China Immunodiagnostics Market
  - 8.4.7.1. Market Size and Forecast, By Product Type
  - 8.4.7.2. Market Size and Forecast, By Technology
  - 8.4.7.3. Market Size and Forecast, By Application
  - 8.4.7.4. Market Size and Forecast, By End-user
- 8.4.8. Japan Immunodiagnostics Market
  - 8.4.8.1. Market Size and Forecast, By Product Type
  - 8.4.8.2. Market Size and Forecast, By Technology
  - 8.4.8.3. Market Size and Forecast, By Application
  - 8.4.8.4. Market Size and Forecast, By End-user
- 8.4.9. India Immunodiagnostics Market
  - 8.4.9.1. Market Size and Forecast, By Product Type
  - 8.4.9.2. Market Size and Forecast, By Technology
  - 8.4.9.3. Market Size and Forecast, By Application
  - 8.4.9.4. Market Size and Forecast, By End-user
- 8.4.10. South Korea Immunodiagnostics Market
  - 8.4.10.1. Market Size and Forecast, By Product Type
  - 8.4.10.2. Market Size and Forecast, By Technology
  - 8.4.10.3. Market Size and Forecast, By Application
  - 8.4.10.4. Market Size and Forecast, By End-user
- 8.4.11. Australia Immunodiagnostics Market
  - 8.4.11.1. Market Size and Forecast, By Product Type
  - 8.4.11.2. Market Size and Forecast, By Technology
  - 8.4.11.3. Market Size and Forecast, By Application
  - 8.4.11.4. Market Size and Forecast, By End-user
- 8.4.12. Rest of Asia-Pacific Immunodiagnostics Market
  - 8.4.12.1. Market Size and Forecast, By Product Type
  - 8.4.12.2. Market Size and Forecast, By Technology
  - 8.4.12.3. Market Size and Forecast, By Application
  - 8.4.12.4. Market Size and Forecast, By End-user
8.5. LAMEA
- 8.5.1. Key Market Trends and Opportunities
- 8.5.2. Market Size and Forecast, By Product Type
- 8.5.3. Market Size and Forecast, By Technology
- 8.5.4. Market Size and Forecast, By Application
- 8.5.5. Market Size and Forecast, By End-user
- 8.5.6. Market Size and Forecast, By Country
- 8.5.7. Brazil Immunodiagnostics Market
  - 8.5.7.1. Market Size and Forecast, By Product Type
  - 8.5.7.2. Market Size and Forecast, By Technology
  - 8.5.7.3. Market Size and Forecast, By Application
  - 8.5.7.4. Market Size and Forecast, By End-user
- 8.5.8. South Africa Immunodiagnostics Market
  - 8.5.8.1. Market Size and Forecast, By Product Type
  - 8.5.8.2. Market Size and Forecast, By Technology
  - 8.5.8.3. Market Size and Forecast, By Application
  - 8.5.8.4. Market Size and Forecast, By End-user
- 8.5.9. Saudi Arabia Immunodiagnostics Market
  - 8.5.9.1. Market Size and Forecast, By Product Type
  - 8.5.9.2. Market Size and Forecast, By Technology
  - 8.5.9.3. Market Size and Forecast, By Application
  - 8.5.9.4. Market Size and Forecast, By End-user
- 8.5.10. Rest of LAMEA Immunodiagnostics Market
  - 8.5.10.1. Market Size and Forecast, By Product Type
  - 8.5.10.2. Market Size and Forecast, By Technology
  - 8.5.10.3. Market Size and Forecast, By Application
  - 8.5.10.4. Market Size and Forecast, By End-user

CHAPTER 9: COMPETITIVE LANDSCAPE

9.1. Introduction
9.2. Top Winning Strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Top Player Positioning, 2023

CHAPTER 10: COMPANY PROFILES

10.1. Abbott
- 10.1.1. Company Overview
- 10.1.2. Key Executives
- 10.1.3. Company Snapshot
- 10.1.4. Operating Business Segments
- 10.1.5. Product Portfolio
- 10.1.6. Business Performance
- 10.1.7. Key Strategic Moves and Developments
10.2. Becton Dickinson
- 10.2.1. Company Overview
- 10.2.2. Key Executives
- 10.2.3. Company Snapshot
- 10.2.4. Operating Business Segments
- 10.2.5. Product Portfolio
- 10.2.6. Business Performance
- 10.2.7. Key Strategic Moves and Developments
10.3. Agilent Technologies, Inc.
- 10.3.1. Company Overview
- 10.3.2. Key Executives
- 10.3.3. Company Snapshot
- 10.3.4. Operating Business Segments
- 10.3.5. Product Portfolio
- 10.3.6. Business Performance
- 10.3.7. Key Strategic Moves and Developments
10.4. Exact Sciences Corporation
- 10.4.1. Company Overview
- 10.4.2. Key Executives
- 10.4.3. Company Snapshot
- 10.4.4. Operating Business Segments
- 10.4.5. Product Portfolio
- 10.4.6. Business Performance
- 10.4.7. Key Strategic Moves and Developments
10.5. Guardant Health
- 10.5.1. Company Overview
- 10.5.2. Key Executives
- 10.5.3. Company Snapshot
- 10.5.4. Operating Business Segments
- 10.5.5. Product Portfolio
- 10.5.6. Business Performance
- 10.5.7. Key Strategic Moves and Developments
10.6. Illumina, Inc.
- 10.6.1. Company Overview
- 10.6.2. Key Executives
- 10.6.3. Company Snapshot
- 10.6.4. Operating Business Segments
- 10.6.5. Product Portfolio
- 10.6.6. Business Performance
- 10.6.7. Key Strategic Moves and Developments
10.7. Diaosorin
- 10.7.1. Company Overview
- 10.7.2. Key Executives
- 10.7.3. Company Snapshot
- 10.7.4. Operating Business Segments
- 10.7.5. Product Portfolio
- 10.7.6. Business Performance
- 10.7.7. Key Strategic Moves and Developments
10.8. NeoGenomics Laboratories
- 10.8.1. Company Overview
- 10.8.2. Key Executives
- 10.8.3. Company Snapshot
- 10.8.4. Operating Business Segments
- 10.8.5. Product Portfolio
- 10.8.6. Business Performance
- 10.8.7. Key Strategic Moves and Developments
10.9. F. Hoffmann-La Roche Ltd.
- 10.9.1. Company Overview
- 10.9.2. Key Executives
- 10.9.3. Company Snapshot
- 10.9.4. Operating Business Segments
- 10.9.5. Product Portfolio
- 10.9.6. Business Performance
- 10.9.7. Key Strategic Moves and Developments
10.10. Thermo Fisher Scientific Inc.
- 10.10.1. Company Overview
- 10.10.2. Key Executives
- 10.10.3. Company Snapshot
- 10.10.4. Operating Business Segments
- 10.10.5. Product Portfolio
- 10.10.6. Business Performance
- 10.10.7. Key Strategic Moves and Developments